ObsEva SA (OBSV)

Last Closing Price: 0.17 (2022-12-08)

Company Description

ObsEva SA is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics for woman's reproductive health and pregnancy. ObsEva SA is headquartered in Geneva, Switzerland.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $20.11M
Net Income (Most Recent Fiscal Year) $-58.38M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) --
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) -1577.83%
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) -416.36%
Return on Assets (Trailing 12 Months) -92.01%
Current Ratio (Most Recent Fiscal Quarter) 0.61
Quick Ratio (Most Recent Fiscal Quarter) 0.61
Debt to Common Equity (Most Recent Fiscal Quarter) 1.18
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $0.41
Earnings per Share (Most Recent Fiscal Quarter) $-0.13
Earnings per Share (Most Recent Fiscal Year) $-0.78
Diluted Earnings per Share (Trailing 12 Months) $-0.92
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 77.97M
Free Float --
Market Capitalization $12.94M
Average Volume (Last 20 Days) 4.10M
Beta (Past 60 Months) 0.45
Percentage Held By Insiders (Latest Annual Proxy Report) --
Percentage Held By Institutions (Latest 13F Reports) 20.12%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%